Meeting
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
Authors
Razelle Kurzrock
Moores Cancer Center, La Jolla, CA
Razelle Kurzrock , Rahul Parulkar , Timothy Joseph Yeatman , Wafik S. El-Deiry , Timothy J. Pluard , Chad Garner , Sandeep K. Reddy
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Tumor-Based Biomarkers
Citation
J Clin Oncol 36, 2018 (suppl; abstr 12118)
DOI
10.1200/JCO.2018.36.15_suppl.12118
Abstract #
12118
Poster Bd #
231
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Parallel sequencing of a 50 genes panel in metastatic colorectal cancer (MCRC) patients (pts) treated with intensive first-line FIr-B/FOx triplet chemotherapy plus bevacizumab (BEV): Preliminary data and clinical outcome.
First Author: Gemma Bruera
Poster
2014 ASCO Annual Meeting
Molecular evaluation of primary tumor (PT) and synchronous liver metastasis in colorectal cancer (srLmCRC) patients after cetuximab-based chemotherapy.
First Author: Daniela Adua
Poster
2019 Gastrointestinal Cancers Symposium
Genomic alterations in appendiceal carcinoma using circulating DNA.
First Author: Walid Labib Shaib
Poster
2014 Gastrointestinal Cancers Symposium
Next-generation sequencing in pancreatic cancer: Revealing genomic mutations beyond KRAS.
First Author: Andrea S. Teague